Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05336695
PHASE1/PHASE2

Assess Fibrin in Brains With AD/ADRD

Sponsor: Massachusetts General Hospital

View on ClinicalTrials.gov

Summary

The goal of this project is to quantify brain fibrin content using 64Cu-FBP8-PET in the brains of subjects ranging from cognitively normal to clinically diagnosed with ADRD to evaluate potential regional differences.

Official title: Assess the Brain Levels of Fibrin in Alzheimer's Disease and Its Related Dementias Subjects Using 64Cu-FBP8 PET

Key Details

Gender

All

Age Range

55 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

30

Start Date

2022-03-29

Completion Date

2026-09-28

Last Updated

2025-10-30

Healthy Volunteers

Yes

Interventions

DIAGNOSTIC_TEST

PET/MR Imaging

PET/MRI Scan with \[64Cu\]FBP8 as directed by protocol

DRUG

64Cu-FBP8

Will be administered by intravenous injection by bolus by a qualified nuclear medicine technician at the Martinos Center

Locations (1)

Massachusetts General Hospital

Boston, Massachusetts, United States